Sign In

Save up to 80% by drug discount in your pharmacy with "Pharmacy Near Me - National Drug Discount Card"

You can scan QR Code(just open camera on your phone/scan by application) from the image on prescription drug discount card to save it to your mobile phone. Or just click on image if you're on mobile phone.

View Generic:
View Brand:

Shiseido white lucent brightening spot-control foundation (refill) o60 - Medication Information

Product NDC Code 52686-255
Drug Name

Shiseido white lucent brightening spot-control foundation (refill) o60

Type Brand
Active Ingredients
Octinoxate .39 g/10g
Titanium dioxide .66 g/10g
Route TOPICAL
Dosage Form PASTE
Application Number part352
Labeler Name SHISEIDO AMERICA INC.
Check if available Online

Active ingredient

A list of the active, medicinal ingredients in the drug product.
ACTIVE INGREDIENTS: Purpose OCTINOXATE 3.9% Sunscreen TITANIUM DIOXIDE 6.6% Sunscreen
ACTIVE INGREDIENTS:Purpose
OCTINOXATE 3.9%Sunscreen
TITANIUM DIOXIDE 6.6%Sunscreen

Dosage and administration

Information about the drug product’s dosage and administration recommendations, including starting dose, dose range, titration regimens, and any other clinically sigificant information that affects dosing recommendations.
Directions For sunscreen use: apply liberally 15 minutes before sun exposure use a water resistant sunscreen if swimming or sweating reapply at least every 2 hours Sun Protection Measures . Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a broad spectrum SPF of 15 or higher and other sun protection measures including: limit time in the sun, especially from 10 a.m. – 2 p.m. wear long-sleeve shirts, pants, hats, and sunglasses children under 6 months: Ask a doctor

Inactive ingredient

A list of inactive, non-medicinal ingredients in a drug product.
Inactive Ingredients SYNTHETIC FLUORPHLOGOPITE, TALC, TRIETHYLHEXANOIN, DIMETHICONE, SILICA, SYNTHETIC WAX, VINYL DIMETHICONE/METHICONE SILSESQUIOXANE CROSSPOLYMER, TRANEXAMIC ACID, ALUMINUM HYDROXIDE, SORBITAN SESQUIISOSTEARATE, POLYMETHYL METHACRYLATE, SODIUM HYALURONATE, ALUMINUM DISTEARATE, POLYSILICONE-2, SODIUM MAGNESIUM SILICATE, GLYCERIN, TOCOPHEROL, BHT, CHLORPHENESIN, FRAGRANCE, MICA, TITANIUM DIOXIDE, IRON OXIDES,

Indications and usage

A statement of each of the drug products indications for use, such as for the treatment, prevention, mitigation, cure, or diagnosis of a disease or condition, or of a manifestation of a recognized disease or condition, or for the relief of symptoms associated with a recognized disease or condition. This field may also describe any relevant limitations of use.
Uses helps prevent sunburn if used as directed with other sun protection measures (see Directions ), decreases the risk of skin cancer and early skin aging caused by the sun

Purpose

Information about the drug product’s indications for use.
ACTIVE INGREDIENTS: Purpose OCTINOXATE 3.9% Sunscreen TITANIUM DIOXIDE 6.6% Sunscreen
ACTIVE INGREDIENTS:Purpose
OCTINOXATE 3.9%Sunscreen
TITANIUM DIOXIDE 6.6%Sunscreen

Spl product data elements

Usually a list of ingredients in a drug product.
SHISEIDO WHITE LUCENT BRIGHTENING SPOT-CONTROL FOUNDATION (REFILL) O00 OCTINOXATE and TITANIUM DIOXIDE OCTINOXATE OCTINOXATE TITANIUM DIOXIDE TITANIUM DIOXIDE MICA TALC TRIETHYLHEXANOIN DIMETHICONE FERRIC OXIDE RED FERROSOFERRIC OXIDE FERRIC OXIDE YELLOW SYNTHETIC WAX (1200 MW) SILICON DIOXIDE TRANEXAMIC ACID ALUMINUM HYDROXIDE ALUMINUM DISTEARATE CHLORPHENESIN GLYCERIN .ALPHA.-TOCOPHEROL BUTYLATED HYDROXYTOLUENE HYALURONATE SODIUM SHISEIDO WHITE LUCENT BRIGHTENING SPOT-CONTROL FOUNDATION (REFILL) O20 OCTINOXATE and TITANIUM DIOXIDE OCTINOXATE OCTINOXATE TITANIUM DIOXIDE TITANIUM DIOXIDE MICA TALC TRIETHYLHEXANOIN DIMETHICONE FERRIC OXIDE RED FERROSOFERRIC OXIDE FERRIC OXIDE YELLOW SYNTHETIC WAX (1200 MW) SILICON DIOXIDE TRANEXAMIC ACID ALUMINUM HYDROXIDE ALUMINUM DISTEARATE CHLORPHENESIN GLYCERIN .ALPHA.-TOCOPHEROL BUTYLATED HYDROXYTOLUENE HYALURONATE SODIUM SHISEIDO WHITE LUCENT BRIGHTENING SPOT-CONTROL FOUNDATION (REFILL) O40 OCTINOXATE and TITANIUM DIOXIDE OCTINOXATE OCTINOXATE TITANIUM DIOXIDE TITANIUM DIOXIDE MICA TALC TRIETHYLHEXANOIN DIMETHICONE FERRIC OXIDE RED FERROSOFERRIC OXIDE FERRIC OXIDE YELLOW SYNTHETIC WAX (1200 MW) SILICON DIOXIDE TRANEXAMIC ACID ALUMINUM HYDROXIDE ALUMINUM DISTEARATE CHLORPHENESIN GLYCERIN .ALPHA.-TOCOPHEROL BUTYLATED HYDROXYTOLUENE HYALURONATE SODIUM SHISEIDO WHITE LUCENT BRIGHTENING SPOT-CONTROL FOUNDATION (REFILL) O60 OCTINOXATE and TITANIUM DIOXIDE OCTINOXATE OCTINOXATE TITANIUM DIOXIDE TITANIUM DIOXIDE MICA TALC TRIETHYLHEXANOIN DIMETHICONE FERRIC OXIDE RED FERROSOFERRIC OXIDE FERRIC OXIDE YELLOW SYNTHETIC WAX (1200 MW) SILICON DIOXIDE TRANEXAMIC ACID ALUMINUM HYDROXIDE ALUMINUM DISTEARATE CHLORPHENESIN GLYCERIN .ALPHA.-TOCOPHEROL BUTYLATED HYDROXYTOLUENE HYALURONATE SODIUM SHISEIDO WHITE LUCENT BRIGHTENING SPOT-CONTROL FOUNDATION (REFILL) BF20 OCTINOXATE and TITANIUM DIOXIDE OCTINOXATE OCTINOXATE TITANIUM DIOXIDE TITANIUM DIOXIDE MICA TALC TRIETHYLHEXANOIN DIMETHICONE FERRIC OXIDE RED FERROSOFERRIC OXIDE FERRIC OXIDE YELLOW SYNTHETIC WAX (1200 MW) SILICON DIOXIDE TRANEXAMIC ACID ALUMINUM HYDROXIDE ALUMINUM DISTEARATE CHLORPHENESIN GLYCERIN .ALPHA.-TOCOPHEROL BUTYLATED HYDROXYTOLUENE HYALURONATE SODIUM SHISEIDO WHITE LUCENT BRIGHTENING SPOT-CONTROL FOUNDATION (REFILL) I00 OCTINOXATE and TITANIUM DIOXIDE OCTINOXATE OCTINOXATE TITANIUM DIOXIDE TITANIUM DIOXIDE MICA TALC TRIETHYLHEXANOIN DIMETHICONE FERRIC OXIDE RED FERROSOFERRIC OXIDE FERRIC OXIDE YELLOW SYNTHETIC WAX (1200 MW) SILICON DIOXIDE TRANEXAMIC ACID ALUMINUM HYDROXIDE ALUMINUM DISTEARATE CHLORPHENESIN GLYCERIN .ALPHA.-TOCOPHEROL BUTYLATED HYDROXYTOLUENE HYALURONATE SODIUM

Package label principal display panel

The content of the principal display panel of the product package, usually including the product’s name, dosage forms, and other key information about the drug product.
PRINCIPAL DISPLAY PANEL - 10g Tray Carton - O00 S HI S EIDO WHITE LUCENT Brightening Spot-Control Foundation (Refill) BROAD SPECTRUM SPF 26 SUNSCREEN 10g NET WT. .35 OZ. Principal Display Panel - 10g Tray Carton - O00 PRINCIPAL DISPLAY PANEL - 10g Tray Carton - O20 S HI S EIDO WHITE LUCENT Brightening Spot-Control Foundation (Refill) BROAD SPECTRUM SPF 26 SUNSCREEN 10g NET WT. .35 OZ. Principal Display Panel - 10g Tray Carton - O20 PRINCIPAL DISPLAY PANEL - 10g Tray Carton - O40 S HI S EIDO WHITE LUCENT Brightening Spot-Control Foundation (Refill) BROAD SPECTRUM SPF 26 SUNSCREEN 10g NET WT. .35 OZ. Principal Display Panel - 10g Tray Carton - O40 PRINCIPAL DISPLAY PANEL - 10g Tray Carton - O60 S HI S EIDO WHITE LUCENT Brightening Spot-Control Foundation (Refill) BROAD SPECTRUM SPF 26 SUNSCREEN 10g NET WT. .35 OZ. Principal Display Panel - 10g Tray Carton - O60 PRINCIPAL DISPLAY PANEL - 10g Tray Carton - BF20 S HI S EIDO WHITE LUCENT Brightening Spot-Control Foundation (Refill) BROAD SPECTRUM SPF 26 SUNSCREEN 10g NET WT. .35 OZ. Principal Display Panel - 10g Tray Carton - BF20 PRINCIPAL DISPLAY PANEL - 10g Tray Carton - I00 S HI S EIDO WHITE LUCENT Brightening Spot-Control Foundation (Refill) BROAD SPECTRUM SPF 26 SUNSCREEN 10g NET WT. .35 OZ. Principal Display Panel - 10g Tray Carton - I00

Spl unclassified section

Information not classified as belonging to one of the other fields. Approximately 40% of labeling with effective_time between June 2009 and August 2014 have information in this field.
Drug Facts SHISEIDO AMERICA INC. NEW YORK, N.Y. 10022 SHISEIDO DIST. NEW YORK • PARIS • MILANO

Do not use

Information about all contraindications for use. These contraindications are absolute and are intended for situations in which consumers should not use the product unless a prior diagnosis has been established by a doctor or for situations in which certain consumers should not use the product under any circumstances regardless of whether a doctor or health professional is consulted.
Do not use on damaged or broken skin

Keep out of reach of children

Information pertaining to whether the product should be kept out of the reach of children, and instructions about what to do in the case of accidental contact or ingestion, if appropriate.
Keep out of reach of children. If product is swallowed, get medical help or contact a Poison Control Center right away.

Questions

A telephone number of a source to answer questions about a drug product. Sometimes available days and times are also noted.
Questions or comments? Call toll free 1-800-906-7503

Stop use

Information about when use of the drug product should be discontinued immediately and a doctor consulted. Includes information about any signs of toxicity or other reactions that would necessitate immediately discontinuing use of the product.
Stop use and ask a doctor if rash occurs

When using

Information about side effects that people may experience, and the substances (e.g. alcohol) or activities (e.g. operating machinery, driving a car) to avoid while using the drug product.
When using this product keep out of eyes. Rinse with water to remove.

Storage and handling

Information about safe storage and handling of the drug product.
Other information protect this product in this container from excessive heat and direct sun.

Warnings

Information about serious adverse reactions and potential safety hazards, including limitations in use imposed by those hazards and steps that should be taken if they occur.
Warnings For external use only Do not use on damaged or broken skin When using this product keep out of eyes. Rinse with water to remove. Stop use and ask a doctor if rash occurs Keep out of reach of children. If product is swallowed, get medical help or contact a Poison Control Center right away.

Disclaimer: Do not rely on openFDA or Phanrmacy Near Me to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Source: OpenFDA, Healthporta Drugs API